Saturday, November 21, 2026
Science
No Result
View All Result
  • Login
  • HOME
  • SCIENCE NEWS
  • CONTACT US
  • HOME
  • SCIENCE NEWS
  • CONTACT US
No Result
View All Result
Scienmag
No Result
View All Result
Home Science News Psychology & Psychiatry

Nano-Selenium Boosts JAK/STAT in Depression

August 12, 2025
in Psychology & Psychiatry
Glenn Wilkins
By Glenn Wilkins Scienmag Editorial Profile - Clinical Psychology
Reading Time: 3 mins read
0
Nano-Selenium Boosts JAK/STAT in Depression
66
SHARES
600
VIEWS
Share on FacebookShare on Twitter
ADVERTISEMENT

In a groundbreaking advancement at the intersection of neuropsychiatry and nanotechnology, recent research has explored the therapeutic potential of nano-selenium supplementation on a critical cellular signaling mechanism implicated in major depressive disorder (MDD). This innovative study, published in the esteemed journal BMC Psychiatry, provides new insights into how modulating molecular pathways might open avenues for adjunct treatments in a condition that affects millions globally.

Major depressive disorder remains one of the most challenging mental health conditions to treat effectively, with complex etiology involving genetic, biochemical, and environmental factors. A growing body of research highlights the pivotal role played by intracellular signaling cascades such as the Janus kinase/signal transducer and activator of transcription (JAK/STAT) pathway in the disease’s pathophysiology. Dysregulation within this pathway, especially alterations in genes like JAK2 and STAT3, has been associated with the manifestation of depressive symptoms, making it an attractive target for novel therapeutic interventions.

The innovative edge of the present study lies in investigating selenium nanoparticles—nano-selenium—for their potential to influence this molecular pathway. Selenium itself is a trace element known for its antioxidant properties, crucial in mitigating oxidative stress that is often elevated in depressive disorders. The nanoscale formulation enhances its bioavailability and cellular uptake compared to standard selenium compounds, raising hopes for more impactful clinical outcomes.

This rigorous triple-blind, randomized controlled trial was meticulously conducted at the Psychosomatic Clinic of Imam Khomeini Hospital Complex in Iran. Fifty adults newly diagnosed with MDD were enrolled and randomized into two groups: one receiving 55 micrograms per day of nano-selenium supplementation alongside standard treatment with sertraline, and the other receiving a placebo with sertraline for a duration of 12 weeks. The triple-blind design ensured that participants, clinicians, and outcome assessors were unaware of group assignments, enhancing the reliability of the findings.

Gene expression analyses through reverse transcription quantitative polymerase chain reaction (RT-qPCR) provided precise measurements of JAK2, STAT3, and IDO1 expression levels pre- and post-intervention. IDO1, or indoleamine 2,3-dioxygenase 1, is an enzyme linked with tryptophan metabolism and inflammatory pathways, both of which are implicated in depression. Monitoring changes in these molecular markers sheds light on the biochemical responses triggered by nano-selenium supplementation.

Results revealed that both groups exhibited significant reductions in the relative gene expression of JAK2 and STAT3 over the 12-week period, indicating a general effect of standard antidepressant treatment combined with either nano-selenium or placebo. However, while the nano-selenium group showed a trend toward more pronounced reductions, these differences did not reach statistical significance when compared directly to the placebo group. The IDO1 expression changes were not significantly highlighted, suggesting the primary impact centered around JAK2 and STAT3 signaling components.

This nuanced outcome carries important implications. It suggests that nano-selenium, despite its enhanced delivery capabilities and antioxidant properties, may require further dose optimization, extended treatment duration, or perhaps combination with other therapeutic modalities to exert a strong modulatory effect on the JAK/STAT pathway. Additionally, individual biological variability and the complex nature of depression-associated molecular changes might have influenced the results.

The researchers emphasize that this is the pioneering human clinical trial examining nano-selenium’s impact on JAK/STAT signaling in MDD, providing a valuable foundation for future investigations. Their work underscores the importance of exploring nano-enabled nutraceuticals as adjunctive therapies in psychiatric conditions, which may one day augment or refine existing pharmacological treatments with fewer side effects or enhanced efficacy.

Moreover, the elucidation of how antioxidants like selenium nanoparticles can alter intracellular signaling adds a new dimension to depression research. It intersects with emerging theories on neuroinflammation, oxidative stress, and neurotransmitter metabolism in MDD, highlighting the complexity of underlying mechanisms and the need for multi-targeted therapeutic approaches.

Future research directions prompted by this study include increasing sample sizes to enhance statistical power, testing varying dosages, and examining longer intervention periods. Additionally, integrating comprehensive behavioral and neurocognitive assessments alongside molecular analyses would help clarify the clinical significance of gene expression modulation observed here.

The ethical rigor and transparent trial registration, approved by the Iran University of Medical Sciences and registered with the Iranian Registry of Clinical Trials, further strengthen the credibility and reproducibility of the findings. These procedural details contribute to the trustworthiness of the data and offer a template for subsequent studies in this domain.

In summary, this pioneering work marks a significant step forward in merging nanotechnology with psychiatric treatment strategies, representing hope for more targeted, mechanism-based therapies for major depression. As our molecular understanding deepens, nanoformulations like selenium nanoparticles may evolve from experimental adjuncts into mainstream components of personalized mental health care.

Subject of Research: Modulation of the JAK/STAT signaling pathway in major depressive disorder through nano-selenium supplementation.

Article Title: Impact of Nano-Selenium supplementation on the JAK/STAT signaling pathway in major depressive disorder: a Triple-Blind, randomized controlled trial.

Article References: Noormohammadi, M., Etesam, F., Amini, A., Dehkordi, P. K., Mohammadzadeh, M., & Shidfar, F. (2025). Impact of Nano-Selenium supplementation on the JAK/STAT signaling pathway in major depressive disorder: a Triple-Blind, randomized controlled trial. BMC Psychiatry, 25(1), Article 785. https://doi.org/10.1186/s12888-025-07213-4

Image Credits: AI Generated

DOI: 10.1186/s12888-025-07213-4

Keywords: adjunct treatments for depressive disorders, antioxidant properties of selenium, genetic factors in major depressive disorder, intracellular signaling in mental health, JAK/STAT pathway in depression, major depressive disorder research, molecular pathways and mental health, nano-selenium supplementation, neuropsychiatry and nanotechnology, oxidative stress and depression, selenium nanoparticles for depression treatment, therapeutic interventions for MDD

Cite Scienmag News

Glenn Wilkins. (August 12, 2025). Nano-Selenium Boosts JAK/STAT in Depression. Scienmag. https://scienmag.com/nano-selenium-boosts-jak-stat-in-depression/

Glenn Wilkins. "Nano-Selenium Boosts JAK/STAT in Depression." Scienmag, 12 August 2025, https://scienmag.com/nano-selenium-boosts-jak-stat-in-depression/. Accessed 21 November 2026.

Glenn Wilkins. "Nano-Selenium Boosts JAK/STAT in Depression." Scienmag. August 12, 2025. https://scienmag.com/nano-selenium-boosts-jak-stat-in-depression/

Tags: adjunct treatments for depressive disordersantioxidant properties of seleniumgenetic factors in major depressive disorderintracellular signaling in mental healthJAK/STAT pathway in depressionmajor depressive disorder researchmolecular pathways and mental healthnano-selenium supplementationneuropsychiatry and nanotechnologyoxidative stress and depressionselenium nanoparticles for depression treatmenttherapeutic interventions for MDD
Share26Tweet17
Previous Post

Cognitive and Brain Growth Predict Youth Psychotic Distress

Next Post

FAU Engineers and Sensing Institute Chart Brain Blood Flow with Neural Navigation Technology

Related Posts

Facial trauma wounds disrupt identity and social functioning in Limpopo patients
Psychology & Psychiatry

Facial trauma wounds disrupt identity and social functioning in Limpopo patients

November 21, 2026
Autonomous Exercise Motivation Linked to Higher Activity and Well-Being in Chinese Adolescents
Psychology & Psychiatry

Autonomous Exercise Motivation Linked to Higher Activity and Well-Being in Chinese Adolescents

November 21, 2026
Exonerees Face Less Stigma and Receive More Support Than Rightfully Convicted Individuals
Psychology & Psychiatry

Exonerees Face Less Stigma and Receive More Support Than Rightfully Convicted Individuals

November 21, 2026
Thyroid Cancer Survivors Face Persistent Psychological Distress Despite Favorable Clinical Prognosis
Psychology & Psychiatry

Thyroid Cancer Survivors Face Persistent Psychological Distress Despite Favorable Clinical Prognosis

November 21, 2026
Hippocampal Brain Circuit Disruptions During Threat Learning Linked to Adolescent Anxiety
Psychology & Psychiatry

Hippocampal Brain Circuit Disruptions During Threat Learning Linked to Adolescent Anxiety

November 21, 2026
Callous-Unemotional Traits Link to Adolescent Bullying Beyond Externalizing Problems
Psychology & Psychiatry

Callous-Unemotional Traits Link to Adolescent Bullying Beyond Externalizing Problems

November 21, 2026
Next Post
FAU Engineers and Sensing Institute Chart Brain Blood Flow with Neural Navigation Technology

FAU Engineers and Sensing Institute Chart Brain Blood Flow with Neural Navigation Technology

  • Mothers who receive childcare support from maternal grandparents show more optimized

    Mothers who receive childcare support from maternal grandparents show more parental warmth, finds NTU Singapore study

    27656 shares
    Share 11059 Tweet 6912
  • University of Seville Breaks 120-Year-Old Mystery, Revises a Key Einstein Concept

    1061 shares
    Share 424 Tweet 265
  • Bee body mass, pathogens and local climate influence heat tolerance

    682 shares
    Share 273 Tweet 171
  • Researchers record first-ever images and data of a shark experiencing a boat strike

    546 shares
    Share 218 Tweet 137
  • Groundbreaking Clinical Trial Reveals Lubiprostone Enhances Kidney Function

    531 shares
    Share 212 Tweet 133
Science

Embark on a thrilling journey of discovery with Scienmag.com—your ultimate source for cutting-edge breakthroughs. Immerse yourself in a world where curiosity knows no limits and tomorrow’s possibilities become today’s reality!

RECENT NEWS

  • Fisetin Protects Weaned Piglets Against Zinc Toxicity by Blocking Gut Ferroptosis
  • Qualitative Study Highlights Tourism Potential of Fethiye Traditional Wedding Foods
  • Trypanosomatid Alternative Oxidases Diverge Into Distinct Functional and Inactive Lineages
  • Marine Phytoplankton Adapt to Acidification by Slashing Cellular Phosphorus Requirements

Categories

  • Agriculture
  • Anthropology
  • Archaeology
  • Athmospheric
  • Biology
  • Biotechnology
  • Blog
  • Bussines
  • Cancer
  • Chemistry
  • Climate
  • Earth Science
  • Editorial Policy
  • Marine
  • Mathematics
  • Medicine
  • Pediatry
  • Policy
  • Psychology & Psychiatry
  • Science Education
  • Science News
  • Social Science
  • Space
  • Technology and Engineering

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 5,151 other subscribers

© 2026 Scienmag - Science Magazine

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • HOME
  • SCIENCE NEWS
  • CONTACT US

© 2026 Scienmag - Science Magazine

Discover more from Science

Subscribe now to keep reading and get access to the full archive.

Continue reading